Key result
Pre-ablation DE-MRI identifies arrhythmogenic scar in ~48% of non-ischemic cardiomyopathy patients to guide ablation.
Why the study?
Ventricular arrhythmias in non-ischemic cardiomyopathy are often associated with scar tissue, and delayed-enhanced MRI precisely defines scar tissue, but its value in guiding catheter ablation required evaluation.
Does delayed-enhanced magnetic resonance imaging (DE-MRI) identify arrhythmogenic substrates and guide ablation in patients with non-ischemic cardiomyopathy?
Cohort (n=29)
Observers blinded to mapping and ablation results for MRI review
Does delayed-enhanced magnetic resonance imaging (DE-MRI) identify arrhythmogenic substrates and guide ablation in patients with non-ischemic cardiomyopathy?
DE-MRI is a valuable tool for identifying scar tissue in non-ischemic cardiomyopathy, helping to plan whether an endocardial or epicardial ablation approach is needed.
Objective The purpose of this study was to assess the value of delayed-enhanced magnetic resonance imaging (DE-MRI) to guide ablation of ventricular arrhythmias in patients with non-ischemic cardiomyopathy (NIC). Background In patients with NIC, ventricular arrhythmias often are associated with scar tissue. DE-MRI can be used to precisely define scar tissue. Methods DE-MRI was performed in 29 consecutive patients (mean age 50±15 years) with NIC (mean ejection fraction 37±9%) referred for catheter ablation of ventricular tachycardia (VT) or premature ventricular complexes (PVCs). Scar was extracted from DE-MRIs and was then integrated into the electroanatomic map. Mapping data were correlated with respect to the localization of scar tissue. Results Scar was identified by DE-MRI in 14/29 patients. Nine of these patients had VT and five had PVCs. In 5 of the patients there was predominantly endocardial scar, and mapping and ablation of arrhythmias was effectively performed from the endocardium in all 5 patients. In 2 patients scar was either intramural or epicardial with extension to the endocardium. In both patients with partial endocardial scar extension, the ablation was effective in eliminating some but not all arrhythmias. In 2 patients most of the scar tissue was confined to the epicardium; mapping identified and eliminated an epicardial origin in both patients. No effect on arrhythmias could be achieved in the other 5 patients with predominantly intramural scar. Conclusions DE-MRI in patients without prior infarctions can help to identify the arrhythmogenic substrate; furthermore it helps to plan an appropriate mapping and ablation strategy.
No takes yet. Share an insight, caveat, or question.
Bogun et al. (2009) conducted a cohort in Non-ischemic cardiomyopathy with ventricular arrhythmias (n=29). Delayed-enhanced magnetic resonance imaging (DE-MRI) was evaluated on Identification of scar tissue by DE-MRI. Delayed-enhanced magnetic resonance imaging identified scar tissue in 14 of 29 patients with non-ischemic cardiomyopathy, and its location reliably guided the mapping and ablation strategy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: